No but since when does any company’s stock price actually reflect a business. You have companies trading at 150x revenue that lose billions a year. You have companies that make billions and are growing, trading at 5x their PE. Nothing makes sense in the market anymore. RXMD mainly trades where it is because of the fact that they don’t make any money and that their core business isn’t growing much anymore. The S1 pumped it up for a while and then after close to a year of zero happening of any significance, here we are back on the low 3’s and possibly moving into the 2’s.
News 
Market Data 
Discover 
